Home > Press > Arrowhead Pharmaceuticals Announces Planned Management TransitionAbstract:Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Bruce Given, M.D., Arrowheads chief operating officer and head of R&D, plans to retire on May 1, 2020, after a more than 30 year career in biotechnology and pharmaceutical research, development, and sales...